Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S916

Introduced
2/27/25  

Caption

To enhance analysis of state health mandates and costs

Impact

If enacted, S916 would impose a moratorium on new health benefit mandates until the state's overall healthcare expenditures meet a predetermined growth benchmark. This stipulation aims to control healthcare costs while ensuring that any new regulations do not contribute to an unsustainable increase in health insurance coverage costs. The bill obliges state entities to carry out a thorough review of any mandated health benefit proposals and the implications for overall expenditures on healthcare within the state.

Summary

Bill S916, introduced by Senator Bruce E. Tarr, seeks to enhance the analysis of state health insurance mandates and their associated costs within Massachusetts. The legislation modifies Chapter 3 of the General Laws, specifically focusing on the process that mandates health benefits, as outlined in Section 38C. The bill emphasizes the necessity for a detailed evaluation of any proposed mandates by state agencies, ensuring transparency and public accessibility to vital information at least 30 days before public hearings.

Contention

A notable point of contention surrounding S916 may arise from various stakeholders, including healthcare providers and insurance companies. Proponents argue that the bill would facilitate better oversight and management of healthcare costs, making necessary adjustments before enacting new mandates that could financially strain the insurance market. On the contrary, opponents may contend that placing a moratorium could delay essential healthcare benefits and services from being made available to residents, particularly those requiring urgent and important health interventions.

Companion Bills

No companion bills found.

Previously Filed As

MA H5159

Enhancing the market review process

MA H4620

Enhancing the market review process

MA S749

Relative to pharmaceutical access, costs and transparency

MA S715

To ensure access to prescription medications

MA S3012

Relative to pharmaceutical access, costs and transparency

MA S2492

Relative to pharmaceutical access, costs and transparency

MA S670

To help patients and reduce healthcare costs by ensuring patient adherence to medications

MA S2499

Relative to pharmaceutical access, costs and transparency

MA H4653

Enhancing the market review process

MA S2520

Relative to pharmaceutical access, costs and transparency

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

CA AB458

Importation of prescription drugs.

CA AB265

Prescription drugs: prohibition on price discount.

CA AB1048

Health care: pain management and Schedule II drug prescriptions.

CA SB1361

Prescription drugs: cost sharing: pharmacy benefit managers.

AZ SB1254

Opioids; containers; labeling; requirements; repeal